Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-336646
Filing Date
2026-08-06
Accepted
2026-08-06 06:55:30
Documents
69
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nuvb-20260630.htm   iXBRL 10-Q 3286777
2 EX-10.1 nuvb-ex10_1.htm EX-10.1 1094822
3 EX-10.4 nuvb-ex10_4.htm EX-10.4 28240
4 EX-31.1 nuvb-ex31_1.htm EX-31.1 18143
5 EX-31.2 nuvb-ex31_2.htm EX-31.2 18217
6 EX-32.1 nuvb-ex32_1.htm EX-32.1 9792
7 EX-32.2 nuvb-ex32_2.htm EX-32.2 8538
8 GRAPHIC img141968529_0.jpg GRAPHIC 22585
  Complete submission text file 0001193125-26-336646.txt   13342698

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvb-20260630.xsd EX-101.SCH 1501871
73 EXTRACTED XBRL INSTANCE DOCUMENT nuvb-20260630_htm.xml XML 2234104
Mailing Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 332-208-6102
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39351 | Film No.: 261245820
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)